Avalyn Pharma Inc. (AVLN)
NASDAQ: AVLN · Real-Time Price · USD
28.78
+0.39 (1.37%)
At close: May 29, 2026, 4:00 PM EDT
29.35
+0.57 (1.98%)
After-hours: May 29, 2026, 7:42 PM EDT
Avalyn Pharma Market Cap
Avalyn Pharma has a market cap or net worth of $1.2 billion as of May 29, 2026.
Market Cap
1.20B
Enterprise Value
1.07B
1-Year Change
n/a
Ranking
Category
Stock Price
$28.78
Market Cap Chart
Since the IPO on April 30, 2026, Avalyn Pharma's market cap has increased from $752.62M to $1.20B, an increase of 59.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.20B | 1.37% |
| May 28, 2026 | 1.19B | 5.85% |
| May 27, 2026 | 1.12B | 0.45% |
| May 26, 2026 | 1.12B | -7.42% |
| May 22, 2026 | 1.21B | 1.51% |
| May 21, 2026 | 1.19B | 1.36% |
| May 20, 2026 | 1.17B | -0.28% |
| May 19, 2026 | 1.18B | 5.56% |
| May 18, 2026 | 1.11B | -10.76% |
| May 15, 2026 | 1.25B | -2.55% |
| May 14, 2026 | 1.28B | -0.68% |
| May 13, 2026 | 1.29B | 3.11% |
| May 12, 2026 | 1.25B | 1.12% |
| May 11, 2026 | 1.24B | 8.20% |
| May 8, 2026 | 1.14B | 1.49% |
| May 7, 2026 | 1.13B | -2.81% |
| May 6, 2026 | 1.16B | 1.02% |
| May 5, 2026 | 1.15B | -5.64% |
| May 4, 2026 | 1.22B | -2.58% |
| May 1, 2026 | 1.25B | 65.78% |
| Apr 30, 2026 | 752.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ArriVent BioPharma | 1.26B |
| Wave Life Sciences | 1.24B |
| Hemab Therapeutics Holdings | 1.24B |
| Maravai LifeSciences Holdings | 1.20B |
| Zenas BioPharma | 1.17B |
| EyePoint | 1.13B |
| Aktis Oncology | 1.13B |
| MannKind | 1.12B |